The California Biotech Law Blog

"IP technology counseling and negotiation."

Author: The Prinz Law Office is a San Francisco Bay area law firm that focuses its intellectual property counseling practice on clients in the high technology, life science, and e-commerce industries.

Blawg Related Categories: Intellectual Property Law • Internet Law • Science & Technology Law • States • California • Legal Information

Recent Posts from The California Biotech Law Blog

Biotech Industry Begins to Assess Likely Impact of New Administration
The biotech industry is beginning to assess what the impact of the new Obama administration is likely to mean for individual biotech companies. A key concern for the industry is the likely financial implications of…
Biotech Facing a Long IPO Dry Spell
The biotech industry is facing the likelihood of a long IPO dry spell, which could extend beyond what is being forecasted in other industries, according to a report by Reuters. According to Reuters, the last…
Genentech Investments Affected by Down Market
The recent plunge in the stock market is not just affecting the investments of the average investor--it is apparently also affecting the investment portfolios of some biotech and pharmaceutical companies such as Genentech, reported the San Francisco Business Times. According to the San Francisco…
IRS Taking Closer Look at Tech Transfer Offices' Activities
The IRS has launched an effort to review universities' tech transfer office activities, reported Biotech Transfer Week. The IRS began mailing out compliance questionnaires last week to four hundred (400) colleges and universities. According to the IRS website,…
Both Roche and Genentech Remain Silent on Status of Acquisition Talks
Both Roche and Genentech are continuing to remain silent on the status of the Roche-Genentech acquisition talks. For now, employees and investors are left hanging as Genentech’s future continues to be uncertain. Analysts apparently had hoped to get an update this week…
Status of SBIR Reauthorization Unclear
The status of SBIR reauthorization is unclear, according to an update by Rick Shindell of the SBIR Insider.. In his October 3rd newsletter, Rick Shindell had pronounced SBIR reauthorization dead. Shindell wrote in his email update the following: Over the…
Which Universities Have the Most Successful Tech Transfer Programs?
Forbes published an interesting article last week which named the universities in this country with the most successful tech transfer programs in terms of rate of return ("ROI"), according to a 2006 survey. At the top of…
South San Francisco-based Novacea Merges with Transcept Pharmaceuticals
South San Francisco-based Novacea announced its merger this week with Transcept Pharmaceuticals. The San Francisco Business Times reported on the terms of the deal as follows: Under terms of the all-stock deal, Novacea . .…
Report Raises Concerns about Medical Identity Theft
Medical identity theft is on the rise, according to a report by the Chicago Tribune. What exactly is medical identity theft? Well, it is when someone steals your identity in order to either submit fraudulent claims…
Genentech Launches Employee Retention Program
Genentech has launched an employee retention program aimed at retaining employees following the recent bid by Roche to acquire Genentech. The Mercury News reported that Genentech's plan is to spend $371 million in cash on…